* Includes only unique trials
Basic Summary : Alzheimers Disease
Product Trial
Competing Candidates
Product Type
Biomarker/MOA
Therapeutic Area
Sponsor
Pipeline Candidates
Marketed Drug
Available For Licensing
Biological Class
Patent Expiry
Sales Data ($ MN)
Contact
Clinical Trial Result
Basic Analysis
Pipeline Candidates
*
Includes only unique trials
* Highest Phase based on
Product+Indication
Sponsor Analysis
*
Includes only unique trials
* Top 8 Sponsor Analysis based on
Indication
Prediction Of Launch
* Based on Product,Indication.
Product Level Competition
*
Includes only unique trials
* Products listed based on
Indication
Sponsor Level Competition
*
Includes only unique trials
* Sponsor listed based on
Indication
Country Wise Analysis
* Country Wise Analysis
Therapeutic Area
*
Includes only unique trials
* Top 8 Therapeutic Area based on
Phase
Country
Trial Id
Start Date
Completion Date
Study Title
Product
Product Type
Biological Class
Industry Type
Biomarker/MOA
Indication
Therapeutic Area
Orignal Trial Phase
Current Dev Phase
Approved/Unapproved(NDA)
Trial Status
Patent Expiry
Terminated Reason
Outcome Measures
Sponsor/Collaborator
Primary Sponsor
Sponsor Type
Sponsor Classification
Licensing Opportunity
ODD/FTA/BTA
Study Design
Study Type
Synonym
| Country | Trial Id | Start Date | Completion Date | Study Title | Product | Primary Product | Synonym | Product Type | Biological Class (If any) | Industry Type | Biomarker/MOA | Indication | Therapeutic Area | Original Trial Phase | Current Development Phase | Marketing Status | Trial Status | Prediction Of Launch | Patent Expiry Date | Sales Data ($ MN) 2023 | Terminated Reason | Outcome Measures | Clinical Trial Result | Sponsor/Collaborator | Primary Sponsor | Sponsor Type | Sponsor Classification | Probable Licensing Opportunity | Expedited Program | Contact Details | Gender | Age | Population Size | Study Design | Study Type | First Posted | Results First Posted | Last Update Posted | Location |
|---|
Remark : Data from January 2000 To December 2023